Comparison between beta‐blockers and calcium channel blockers in patients with atrial fibrillation according to renal function
Key Points:
- Compares the effectiveness of beta-blockers vs. calcium channel blockers for rate control in AF patients across different renal function levels.
- Assesses cardiovascular outcomes, adverse effects, and mortality risks associated with each drug class.
- Highlights the importance of renal function assessment in personalized AF management.
Description
“Comparison Between Beta-Blockers and Calcium Channel Blockers in Patients With Atrial Fibrillation According to Renal Function” evaluates the efficacy and safety of these two drug classes in AF patients with varying degrees of renal impairment. The study provides insights into optimizing rate control strategies while minimizing adverse outcomes.
Be the first to review “Comparison between beta‐blockers and calcium channel blockers in patients with atrial fibrillation according to renal function”
Reviews
There are no reviews yet.